Phase I/IIa Trial of Atorvastatin in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysm
Adriana H. Tremoulet(George Washington University Hospital), Jane C. Burns(Rady Children's Hospital-San Diego), Samuel R. Dominguez(University of Colorado Denver), Elizabeth Duxbury(University of California San Diego), Pei‐Ni Jone(Northwestern University), Sonia Jain(University of Antwerp), Robert L. Padilla(University of California San Diego), John C. Whitin(Dartmouth College), Joan Pancheri(University of California San Diego), Alessandra Franco(University of California San Diego), Emelia Bainto(University of California San Diego), Heather Heizer, Brookie M. Best, Chisato Shimizu(University of California San Diego), Mary P. Glodé, Harvey J. Cohen(Lucile Packard Children's Hospital), Beth F. Printz(Columbia University Irving Medical Center), Marsha S. Anderson(Children's Hospital Colorado), Feng He(Shanghai University of Traditional Chinese Medicine)
Cited by 39
Related Papers
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
|Circulation|2017|3.7k
Prevention of Infective Endocarditis
|Circulation|2007|2.8k
Traumatic brain injury: progress and challenges in prevention, clinical care, and research
|The Lancet Neurology|2022|1.5k
A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome
|New England Journal of Medicine|1991|1.2k